Literature DB >> 19495934

Focus on headache as an adverse reaction to drugs.

Anna Ferrari1, Luca Spaccapelo, Daniela Gallesi, Emilio Sternieri.   

Abstract

There are a large number of drugs inducing headache as an adverse reaction. Nevertheless, headaches as adverse reactions to drugs have received limited attention. Non-serious adverse reactions, such as headache, are not quantified and described as accurately as serious, life threatening ones. However, non-serious reactions can also be extremely troublesome, above all when they are chronic: they can affect patients' quality of life and contribute to non-compliance. It is absolutely possible that the number of patients with headache as an adverse reaction, which is going to increase, considering the growing use of medications. Physicians should, therefore, be aware of this issue. Indeed, it is difficult to attribute the diagnosis of adverse drug reaction to a condition, headache, which is also a very common symptom in general population.

Entities:  

Mesh:

Year:  2009        PMID: 19495934      PMCID: PMC3451740          DOI: 10.1007/s10194-009-0127-1

Source DB:  PubMed          Journal:  J Headache Pain        ISSN: 1129-2369            Impact factor:   7.277


  43 in total

Review 1.  Idiosyncratic drug reactions: a mechanistic evaluation of risk factors.

Authors:  B K Park; M Pirmohamed; N R Kitteringham
Journal:  Br J Clin Pharmacol       Date:  1992-11       Impact factor: 4.335

Review 2.  Medication-attributed adverse effects in placebo groups: implications for assessment of adverse effects.

Authors:  Winfried Rief; Jerry Avorn; Arthur J Barsky
Journal:  Arch Intern Med       Date:  2006-01-23

3.  Migraine with aura after administration of sublingual nitroglycerin tablets.

Authors:  J Bánk
Journal:  Headache       Date:  2001-01       Impact factor: 5.887

4.  Recurrence of migraine with aura due to tacrolimus therapy in a liver transplant recipient successfully treated with sirolimus substitution.

Authors:  Cory C Toth; Kelly Burak; Werner Becker
Journal:  Headache       Date:  2005-03       Impact factor: 5.887

Review 5.  Do standard doses of frequently prescribed drugs cause preventable adverse effects in women?

Authors:  Jay S Cohen
Journal:  J Am Med Womens Assoc (1972)       Date:  2002

6.  A nitric oxide donor (nitroglycerin) triggers genuine migraine attacks.

Authors:  L L Thomsen; C Kruuse; H K Iversen; J Olesen
Journal:  Eur J Neurol       Date:  1994-09       Impact factor: 6.089

7.  Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit: a prospective study of 1756 patients.

Authors:  Marilisa Franceschi; Carlo Scarcelli; Valeria Niro; Davide Seripa; Anna Maria Pazienza; Giovanni Pepe; Anna Maria Colusso; Luigi Pacilli; Alberto Pilotto
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

8.  Adverse drug reaction reporting by patients in the Netherlands: three years of experience.

Authors:  Joyce de Langen; Florence van Hunsel; Anneke Passier; Lolkje de Jong-van den Berg; Kees van Grootheest
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

9.  Women encounter ADRs more often than do men.

Authors:  Y Zopf; C Rabe; A Neubert; K G Gassmann; W Rascher; E G Hahn; K Brune; H Dormann
Journal:  Eur J Clin Pharmacol       Date:  2008-07-05       Impact factor: 2.953

10.  Net efficacy adjusted for risk (NEAR): a simple procedure for measuring risk:benefit balance.

Authors:  José N Boada; Carlos Boada; Mar García-Sáiz; Marcelino García; Eduardo Fernández; Eugenio Gómez
Journal:  PLoS One       Date:  2008-10-31       Impact factor: 3.240

View more
  9 in total

1.  Comparing adverse event rates of oral blood glucose-lowering drugs reported by patients and healthcare providers: a post-hoc analysis of observational studies published between 1999 and 2011.

Authors:  Liana Hakobyan; Flora M Haaijer-Ruskamp; Dick de Zeeuw; Daniela Dobre; Petra Denig
Journal:  Drug Saf       Date:  2011-12-01       Impact factor: 5.606

2.  Cluster-like headache attacks triggered by nitrofurantoin intake.

Authors:  Ilaria Casetta; Jay Guido Capone
Journal:  Eur J Clin Pharmacol       Date:  2013-10-22       Impact factor: 2.953

3.  Pharmacokinetics and Safety of the Nucleoside Analog Antiviral Drug Galidesivir Administered to Healthy Adult Subjects.

Authors:  Amanda Mathis; David Collins; Sylvia Dobo; Dennis M Walling; William P Sheridan; Ray Taylor
Journal:  Clin Pharmacol Drug Dev       Date:  2022-02-19

Review 4.  Future drugs for migraine.

Authors:  Ivano Farinelli; Sergio De Filippis; Gabriella Coloprisco; Serena Missori; Paolo Martelletti
Journal:  Intern Emerg Med       Date:  2009-06-24       Impact factor: 3.397

Review 5.  A review of methods used in assessing non-serious adverse drug events in observational studies among type 2 diabetes mellitus patients.

Authors:  Liana Hakobyan; Flora M Haaijer-Ruskamp; Dick de Zeeuw; Daniela Dobre; Petra Denig
Journal:  Health Qual Life Outcomes       Date:  2011-09-29       Impact factor: 3.186

6.  Headache as an Adverse Reaction to the Use of Medication in the Elderly: A Pharmacovigilance Study.

Authors:  Cristina Monteiro; Beatriz Dias; Maria Vaz-Patto
Journal:  Int J Environ Res Public Health       Date:  2021-03-07       Impact factor: 3.390

7.  Frequency and Duration of Early Non-serious Adverse Events in Patients with Rheumatoid Arthritis and Psoriatic Arthritis Treated with Tofacitinib.

Authors:  Ara Dikranian; David Gold; Louis Bessette; Peter Nash; Valderilio F Azevedo; Lisy Wang; John Woolcott; Andrea B Shapiro; Annette Szumski; Dona Fleishaker; Jürgen Wollenhaupt
Journal:  Rheumatol Ther       Date:  2021-12-17

Review 8.  Imaging in headache disorders.

Authors:  Jason C Ray; Elspeth J Hutton
Journal:  Aust Prescr       Date:  2022-06-01

9.  Polypharmacy Among Headache Patients: A Cross-Sectional Study.

Authors:  Anna Ferrari; Carlo Baraldi; Manuela Licata; Cecilia Rustichelli
Journal:  CNS Drugs       Date:  2018-06       Impact factor: 5.749

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.